Study to Determine the Efficacy and Safety of Docetaxel and Doxorubicin With INGN 201 in Locally Advanced Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Locally Advanced Breast Cancer (LABC)
Interventions: GENETIC: INGN 201
Sponsor: Introgen Therapeutics